The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial – Take Retirement Easy

Cleo Diagnostics (COV:AU) has announced The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial

Download the PDF here.

This post appeared first on investingnews.com

Previous Article

Investing

Black Mountain Phase 2 Program has Commenced

November 27, 2024

Investing

Investor Presentation Annual General Meeting

November 27, 2024

Input your search keywords and press Enter.